Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/1510
Full metadata record
DC FieldValueLanguage
dc.contributor.authorХудайбердиев, Хужамурат-
dc.date.accessioned2022-01-05T05:57:06Z-
dc.date.available2022-01-05T05:57:06Z-
dc.date.issued2021-
dc.identifier.other10.5923/j.ajmms.20211106.03-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/1510-
dc.description.abstractThe effectiveness of the medicine- Convaren for restoration of bile-forming function of liver was studied in comparison with Celagrip, Lesbokhol, Liv.52, and Silibor on tetracycline induced acute hepatitis model. Experimental studies were conducted on white male rats with an initial body weight of 170-200 g. The drug lesion was reproduced by daily oral administration of tetracycline at a dose of 500 mg/kg into the stomach using a metal probe for 5 days. The animals were treated with Celagrip (25 mg/kg), Lesbokhol (25 mg/kg), Convaren (50 mg/kg), Liv.52 (100 mg/kg), and Silibor (80 mg/kg) for 6 days. Under the influence of Convaren, the excretion of bile increased by 48,2%, bile acids excretion increased by 89,6%, cholesterol by 94,8%, and bilirubin by 32,6% in tetracycline-induced hepatitis. Convaren showed a more significant impact on the improvement of the bile-secretion activity of the liver in drug-induced hepatitis compared with Silibor, Liv.52, Celagrip and Lesbokhol.en_US
dc.language.isoenen_US
dc.publisherAmerican Journal of Medicine and Medical Sciencesen_US
dc.relation.ispartofseries11(6);-
dc.subjectDrug-induced hepatitis, Hepatoprotective activity, Bile formation, Lipid peroxidation, Antioxidantsen_US
dc.titleEvaluation of the Pharmacological and Therapeutic Effects of Drugs of Natural Origin in the Management of Biliary Insufficiency in Tetracycline Induced Hepatitisen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
9. Khudaiberdiev Kh. I.pdf117.24 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.